Anaplastic Thyroid Cancer
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (2) | BRAF p.V600E | Anaplastic Thyroid Cancer | Dabrafenib, Trametinib | |
| FDA (1) | v::RET | Anaplastic Thyroid Cancer | Selpercatinib | |
| FDA (1) | TSC1 oncogenic variants | Anaplastic Thyroid Cancer | Everolimus | |
| FDA (1) | TSC2 oncogenic variants | Anaplastic Thyroid Cancer | Everolimus |